Mr. Yoav Raiter reports
RELAY & FIO ANNOUNCE AGREEMENT WITH UNISYS CORP. (NYSE: UIS) TO MARKET A COMBINED SOLUTION FOR COVID-19 AND BIOSECURITY MARKET NEEDS
Relay Medical Corp. and Fio Corp. -- together through their joint venture Fionet Rapid Response Group (FRR) -- have entered an agreement with the global IT solutions company Unisys Corp. for jointly marketing a combined solution which includes FRR's Fionet platform for pandemic and biosecurity management, for the large, underserved biosecurity market.
FRR's Fionet platform for pandemic and biosecurity management will be integrated with Unisys's best-in-class
U-Pass, which digitally authenticates individuals' health status. This combination of Fionet mobile testing, triage and reporting capabilities, and U-Pass's mobile authentication technologies will both increase and simplify biosecurity management capability for clients from markets such as large enterprises, governments, transport and maritime industries.
"Our goal is to create a safer environment for any public or private organization in any industry looking to bring employees, guests and students back in large numbers, quickly," said
Chris Kloes, vice-president, cybersecurity solutions, Unisys.
"Together with FRR, we provide an integrated, secure testing and digital health management solution that can be scaled to organizations of any size, allowing our clients to gain better control over who can access their environment."
The market for COVID-19 diagnostic products and services is expected to exceed $84-billion (U.S.). FRR and Unisys believe they have a well-differentiated, end-to-end offering by combining technologies, marketing, and service and support capabilities.
"We are very excited to be working with Unisys, and to continue to grow with other strategic relationships and industry leaders to collaborate and provide innovative market solutions. Our expertise in technology and infectious disease testing has been successful around the world for a variety of use cases, treating over one million patients," said
Yoav Raiter, chief executive officer of Relay Medical.
"Unisys has a powerful market presence in IT solutions and business processes that we are excited to begin integrating with as we evaluate the many potential benefits of joining our technical strengths to achieve market penetration."
Unisys is a leading global IT solutions company that brings technological innovation to businesses and governments around the world. The company provides state-of-the-art solutions, such as the U-Pass comprehensive COVID-19 testing and health management solution, which was developed in response to the coronavirus pandemic. Unisys drives secure, reliable and advanced industry-leading digital workplace, cloud and infrastructure, enterprise computing, and business processing solutions. Proudly integrating security into all of its IT and digital offerings, Unisys delivers a world-class software operating environment.
"This pandemic isn't a transient event, nor will life after COVID equal life before COVID. It is a new era for this whole, interconnected world. In this new era, FRR is in a strong position to make a great contribution to protecting people, jurisdictions and economic activity, and to build its business by doing that. FRR is making careful alliances with substantial companies such as Unisys, with massive capabilities to create large-scale, durable solutions and customer relationships,"
said Dr. Michael Greenberg, chief executive officer of FRR.
FRR's Fionet platform enables fast, scalable, quality-controlled testing and real-time automatic digital results for electronic reporting. Fionet supports frontline testing, and continuously captures and transmits comprehensive data to a centralized aggregation point. In real time, the Fionet portals allow off-site supervisors to track and direct frontline action, displaying accurate epidemiological information and providing actionable insights.
The company has granted an aggregate of 500,000 options to purchase common shares of the company at 25 cents per common share and expiring five years from the date of grant, to certain officers, directors and consultants of the company.
About Relay Medical Corp.
Relay Medical is a technology innovator headquartered in Toronto, Canada, focused on the development of novel solutions in the diagnostics, artificial intelligence data science and Internet of Things security sectors. Relay recently acquired Cybeats Technologies, a platform which offers a holistic approach to cybersecurity and addresses the $73-billion Internet of Things security market through its software bill of materials and microagent solution. Cybeats provides real-time cybersecurity for connected devices, critical infrastructure, automotive, medical and IoT sectors.
The company is holding a special meeting to approve a name change on Sept. 20, 2021, as the company's core competencies and product offerings have organically grown beyond the medical device industry, and this expansion into new industries and businesses will be reflected in the name change. The company's new name will more aptly and effectively communicate the business and its commercial verticals.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.